IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12479853 B1

PDFFull Text
Date of Patent:
Nov. 25, 2025

Filed:

Jun. 27, 2024

Hiv inhibitor compounds

Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Elizabeth M. Bacon, Burlingame, CA (US);

Elbert Chin, San Mateo, CA (US);

Jeromy J. Cottell, Redwood City, CA (US);

Ashley Anne Katana, North Olmstead, OH (US);

Darryl Kato, San Francisco, CA (US);

John O. Link, San Francisco, CA (US);

Nathan Shapiro, Belmont, CA (US);

Teresa Alejandra Trejo Martin, Belmont, CA (US);

Zheng-Yu Yang, Palo Alto, CA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:

Fish & Richardson P.C.

Primary Examiner:

Clinton A Brooks

Assistant Examiner:

Izabela undefined Schmidt

Int. Cl.
CPC ...
C07D 487/08 (2006.01); A61K 31/18 (2006.01); A61K 31/52 (2006.01); A61K 31/55 (2006.01); A61K 31/553 (2006.01); A61K 31/685 (2006.01); A61K 31/688 (2006.01); A61K 45/06 (2006.01); A61P 31/18 (2006.01); C07C 243/28 (2006.01); C07C 275/16 (2006.01); C07D 243/28 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/14 (2006.01); C07D 471/08 (2006.01); C07D 487/10 (2006.01); C07D 491/04 (2006.01);
U.S. Cl.
CPC ...
C07D 487/08 (2013.01); A61K 31/52 (2013.01); A61K 31/55 (2013.01); A61K 31/553 (2013.01); A61K 31/685 (2013.01); A61K 31/688 (2013.01); A61K 45/06 (2013.01); A61P 31/18 (2018.01); C07C 243/28 (2013.01); C07C 275/16 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/14 (2013.01); C07D 471/08 (2013.01); C07D 487/10 (2013.01); C07D 491/04 (2013.01);
Abstract

The invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I.

Find Patent Forward Citations

Loading…